Cochrane · systematic review · CD003999
Relapse prevention interventions for smoking cessation
Livingstone‐Banks, J, Norris, E, Hartmann‐Boyce, J, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 40%Moderate 3 · 60%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 3 versionsBehavioural interventions for assisted abstainers
Population: people who have quit smoking using a cessation intervention
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Smoking cessation | RR 0.98 [0.87, 1.11] | 11 studies · 5523 participants | Moderate Downgraded: risk of bias, inconsistency |
Pharmacotherapy for assisted abstainers
Population: people who have quit smoking using a cessation intervention
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
NRT versus placebo Smoking cessation | RR 1.04 [0.77, 1.4] | 2 studies · 553 participants | Low Downgraded: imprecision |
Bupropion versus placebo Smoking cessation | RR 1.15 [0.98, 1.35] | 6 studies · 1697 participants | Moderate Downgraded: imprecision, inconsistency |
Combination NRT & bupropion versus placebo Smoking cessation | RR 1.18 [0.75, 1.87] | 2 studies · 243 participants | Low Downgraded: imprecision |
Varenicline versus placebo Smoking cessation | RR 1.23 [1.08, 1.41] | 2 studies · 1297 participants | Moderate Downgraded: imprecision, inconsistency |